Is NHS ready to use real-world data to find new therapies and ways to bring drugs to patients?
Real World Evidence
Medtech companies can provide the tools to empower patients and HCPs.
Pharma must prepare its case meticulously to support its new drug applications.
Putting the who, where and why of real-world studies into context.
Drugs development in 2017 looks very different to how it did 10 years ago, and it’s still evolving.
10/03/2017February 8, 2017
Pharma must be prepared to work collaboratively to establish the best benefit-risk profiles and outcomes.
mHealth tech can provide longer-term monitoring for clinical trials.
RWE must become a fundamental accompaniment to traditional RCT data.